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Tetanus toxin, a potent neurotoxin which blocks neurotransmitter r lease in the CNS, also inhibits Ca 2+-induced cate- 
cholamine r lease from digitonin-permeabilized, but not from intact bovine chromaffm cells. In searching for intracellular 
targets for the toxin we studied the binding of affinity-purified tetanus toxin to bovine adrenal chromaffin granules. Teta- 
nus toxin bound in a neuraminidase-sensitive fashion to intact granules and to isolated granule membranes, asassayed 
biochemically and visualized by electron microscopic techniques. The binding characteristics of the toxin to chromaffin 
granule membranes are very similar to the binding of tetanus toxin to brain synaptosomal membranes. We suggest that 
the toxin-binding site is a glycoconjugate of the G lb type (a polysialoganglioside or aglycoprotein-proteoglycan) which 
is localized on the cytoplasmic face of the granule membrane and might directly be involved in exocytotic membrane 
fusion. 
Chromaflin granule; Tetanus toxin; Catecholamine s cretion; Polysialoglyconjugate; Exocytosis; (Chromaffin cell) 
1. INTRODUCTION 
Tetanus toxin (TT), the 150kDa protein 
secreted by Clostridium tetani is a powerful 
bacterial neurotoxin which produces spastic 
paralysis and death in rodents and humans, in the 
range of  nanograms per kg body weight [1]. 
Tetanus toxin is recognized by peripheral neurons, 
internalized, and transported in a retrograde 
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Abbreviations: GDlb, galactosyl-N-acetylgalactosaminyl-[N- 
acetylneuraminyl - N- acetylneuraminyl]galactosylglucosylcer - 
amide; GTIb, galactosyl-N-acetylgalactosaminyl-[N-acetylneu- 
raminyl-N-acetylneuraminyl-N-acetylneuraminyl]galactosylglu_ 
cosylceramide; TeToB, tetanus toxin 'B' form, affinity purified 
on a 'Glb' ganglioside gel; TT, tetanus toxin 
fashion to the central nervous system, where it 
blocks neurotransmitter release [2]. Ample 
evidence implicates GT lb  and GDlb  polysialo- 
gangliosides as receptors for the toxin on neuronal 
membranes [3]. Despite this evidence, it is not 
known whether intracellular binding of  TT to 
polysialogangliosides is necessary for axonal 
transport [4] or for the toxin-evoked inhibition of  
neurotransmitter release [5]. From a clinical van- 
tage point, despite preventive immunization, 
tetanus remains a potentially significant health 
problem due to the inability to reverse the course 
of  the disease once the toxin is internalized. Identi- 
fying the intracellular targets of  TT might lead to 
an understanding of  how the toxin causes the 
pathological responses and could help in develop- 
ment o f  new approaches to inactivate the toxin, 
even after it has interacted with the central nervous 
system. 
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Adrena l  chromaf f in  cells are wel l -character ized 
cel lu lar  models  for  studying exocytot ic  
neurot ransmi t te r  release [6]. Whi le  tetanus toxin 
does not  interfere with catecho lamine  release f rom 
intact  bov ine  chromaf f in  cells [7], mic ro in jec t ion  
o f  the toxin into intact  cells [8], or add i t ion  o f  TT  
to d ig i ton in -permeabi l i zed  chromaf f in  cells [9] was 
shown to inhibit  exocytosis ,  suggest ing the ex- 
istence o f  an intracel lu lar  target site for  the toxin 
act ion.  More  recently,  Ahner t -H i lger  et al. [10] 
demonst ra ted  that  the l ight chain o f  tetanus toxin 
inh ib i ted the release o f  [3H]noradrenal ine f rom 
chromaf f in  cells permeabi l i zed  with streptolys in O 
[10]. Us ing a homogeneous ,  G lb  ( [N-acety lneur-  
aminy l -N-acety lneuraminy l ]  galactosylg lucosyl -  
ceramide)  a f f in i ty  pur i f ied tetanus toxin probe  
[11], named tetanus toxin 'B '  (TeToB) ,  we studied 
the inh ib i tory  effect  o f  this tox in on ca lc ium-  
induced catecho lamine  secret ion f rom permeabi l i z -  
ed chromaf f in  cells. The  same TeToB probe  was 
also used to character ize and,  for  the first t ime, to 
visual ize neuramin idase-sens i t ive  t tanus toxin-  
b ind ing  sites on  the cytop lasmic  face o f  isolated 
chromaf f in  granule  membranes .  As in ferred f rom 
their  b ind ing character ist ics,  these sites appear  to 
be po lys ia locon jugates  o f the GDlb  or  GT lb  type 
and might  be direct ly invo lved in the exocytot ic  
release o f  neurot ransmit ters .  
2. MATERIALS  AND METHODS 
2.1. Chromaffin cell cultures and catecholamine r lease 
Bovine adrenal chromaffin ceils were isolated and cultured as 
previously described [12]. Three-day-old cultures were 
permeabilized [13] with 20/~M digitonin for 10 min in calcium- 
free buffer (containing 1mM EGTA) in the absence or presence 
of increasing tetanus toxin concentrations. After 10 rain, the 
media were changed and the cells were incubated in the same 
buffer (basal release) or in buffer containing 20/~M free ionized 
calcium. After additional 10 min, the supernatants were col- 
lected and centrifuged to remove floating cells and cellular 
debris. Aliquots from the supernatants and the freeze/thawed 
pellets were assayed for catecholamine contents fluorimetrical- 
ly, using a modified trihydroxyindole technique [14]. The 
results were calculated: 
Net release (%) = 
Ca2+-stimulated release - basal release 
total catecholamine content 
and the data are presented as percent of control (cells without 
toxin). The experiments, carried out in triplicates, were 
repeated twice with similar results; the standard error within 
each experiment was < 5°70. 
2.2. Tetanus toxin binding to chromaffin granules 
Chromaffin granules were isolated from intact adrenal 
medulla by sequential centrifugation and further purified over 
a 1.3 M discontinuous ucrose gradient according to [15]. 
Binding of 125I-tetanus toxin B form (192 Ci/mmol), purified 
by the ganglioside-affinity chromatography [9], was performed 
for 2 h at 37°C with either increasing concentrations or with a 
fixed concentration of toxin of 4 x 10 -9 M/sample in 0.32 M 
sucrose containing 25 mM Tris-HC1, pH 7.4, using 360 mg 
granule protein/ml. For some of the experiments, the granules 
were pretreated with 50 mU/ml neuraminidase for 30 min at 
37°C prior to the binding studies. Throughout the experiments 
we used a highly purified neuraminidase from Vibrio cholerae 
(Behringwerke), which is free of proteolytic activity as assayed 
with ~2SI-casein [16]. The pH, saturation, and displacement ex- 
periments were performed by a solid-surface radioreceptor 
assay as previously described [16,17]. Freshly prepared 
chromaffin granules (3.6 mg protein/ml) pretreated with 
neuraminidase or untreated were incubated in suspension with 
the tetanus toxin at 4°C or 37°C. In some experiments, granules 
were lysed by osmotic shock or repeated freezing and thawing, 
as previously described [18] to yield right-side-out oriented 
granule membrane vesicles (ghosts). After 2 h the binding was 
stopped, the medium removed and the granules washed; 
neuraminidase (50 mU/ml) was added to selected tubes and the 
radioactivity associated with the granules after 30 min at 37°C 
was determined [16]. For the displacement experiments, 
chromaffin granules were incubated with t25I-labeled tetanus 
toxin for 2 h at 37°C, and then the granules were washed and 
the unlabeled toxin or ganglioside was added for an additional 
30 min at 37°C. After two rinses, the granule-associated 
radioactivity was counted. In all experiments nonspecific 
binding of 12~I-TeToB was defined as the amount of radioac- 
tivity found in the presence of excess (1 unit of antitoxin) [19]. 
This value represents less than 15070 of the largest value deter- 
mined and was subtracted from all data presented. The values 
are expressed as percent of maximal binding. The binding 
values are the mean of triplicate determinations. The standard 
errors for all experiments were less than 507o. 
2.3. Electron microscopy 
Freshly prepared suspensions of chromaffin granules (2.5 mg 
protein/sample) were incubated for 2h at 37°C with 
biotinylated tetanus toxin (5 × 10 -8 M) purified by 
chromatofocussing and Glb-ganglioside affinity chromatog- 
raphy [20]. After washing and gentle fixation (5 min, room 
temperature with 2.5070 glutaraldehyde, 5070 sucrose in 0.1 M 
sodium cacodylate buffer, pH 7.3) the granules were incubated 
with streptavidin-gold (20 nm diameter) for 1 h at room 
temperature followed by fixation, processing and embedding 
for electron microscopy by conventional methods. Thin sec- 
tions, lightly stained with lead acetate, were examined at 80 kV 
in a Philips 400 electron microscope. To assess the specificity of 
the TT binding, aliquots of the granule suspensions were 
pretreated with 50 mU/ml neuraminidase, asdescribed above. 
In another set of control experiments, the biotinylated toxin 
was omitted to permit evaluation of the nonspecific binding of 
streptavidin-gold. 
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3. RESULTS AND DISCUSSION 
The secretion of catecholamines from intact 
chromaffin cells is believed to be triggered by a rise 
in cytosolic [Ca2+], resulting in exocytotic fusion 
of the secretory vesicular membranes with the 
plasma membrane [6]. This process can be mimick- 
ed in detergent-permeabilized c lls by using buf- 
fered media containing controlled concentrations 
of free, ionized calcium in the micromolar ange 
[21]. To access the intracellular machinery which 
might be involved in the action of tetanus toxin, 
chromaffin cells were permeabilized by exposure 
to 20/~M digitonin [13] for 10 rain in the absence 
or presence of 10-1t-10 -6 M of the ganglioside af- 
finity purified tetanus toxin (TeToB). Subsequent- 
ly, in the continued presence of the toxin or in its 
absence, the cells were exposed to a medium con- 
taining 20/~M ionized calcium. The inhibition of 
the calcium-induced catecholamine s cretion from 
permeabilized chromaffin cells in the presence of 
the toxin is dose dependent with an ICso value of 
approx. 5 × 10 -a M toxin (fig.l). This ICso value 
is comparable to the half-maximal concentration 
of TT required to block catecholamine r lease in 
digitonin-permeabilized chromaffin cells [9] and 
also to the efficacy of the holotoxin in blocking ex- 
ocytosis from streptolysin O-treated cells [10]. 
Concentrations higher than 10 -6 M were required 
to completely block catecholamine s cretion in this 
system (data not shown). By contrast, another 
tetanus toxin, the Glb ganglioside, low-affinity, 
previously isolated and characterized (TeToA) [11] 
was unable to inhibit the calcium-induced 
catecholamine r lease when tested under the same 
experimental conditions, even at concentrations 
exceeding 10-4M (not shown). These findings 
underline that binding of TT to its high-affinity 
receptor is a necessary step to impair exocytosis. 
In line with previously published reports [7], 
catecholamine secretion from intact chromaffin 
cells, either the basal one or the one stimulated by 
either 100/zM acetylcholine or 50 mM potassium, 
could not be inhibited by TeToB at concentrations 
up to l0 -5 M and prolonged preincubations up to 
48 h (data not shown). 
The simplest interpretation of these results is 
that the site of action of tetanus toxin is an in- 
tracellular one and that TT is not internalized by 
intact bovine adrenal chromaffin cells. However, 
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Fig.1. Inhibition of calcium-induced catecholamine r lease 
from digitonin-permeabilized chromaffin cells by ganglioside 
affinity purified tetanus toxin. For details ee section 2. In the 
particular experiment depicted, the basal release was 6.5% and 
the Ca2+-induced release was 17.1070. The degree of inhibition 
is thus normalized to the net release in the absence of TT 
(= l 1.6°70 of the total contents). 
once TT gains access to the cytoplasm, as in 
detergent-permeabilized cells, the calcium- 
dependent secretory response from these cells is in- 
hibited by the Gdlb-specific, high affinity tetanus 
toxin (TeToB) at a site distal to calcium entry, 
presumably by interfering with the site of ex- 
ocytosis proper. The ICso value obtained in our ex- 
periments i  in the range of 104-105 median lethal 
doses to mice and is comparable to those of 
another toxin, botulinum type D, required to in- 
hibit Ca2+-induced catecholamine release from 
electrically permeabilized chromaffin cells [7]. 
With both toxins, the IC~0 values are higher than 
those required to block depolarization-induced 
release of inhibitory neurotransmitters (glycine, 
GABA) in neuronal cells, which are in the range of 
10-s-10 -11 M toxin [5]. This result is not surpris- 
ing given the notion that the secretory machinery 
in permeabilized cells might lack some essential 
components that are present in intact cells [22]. 
To elucidate the site of action of tetanus toxin 
we studied its binding to intact chromaffin cells, 
and to isolated chromaffin granules. Intact 
chromaffin cells, tested either in suspension or as 
monolayers, did not express any saturatable, cell 
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gig.2. Binding of affinity purified tetanus toxin to control and 
neuraminidase-treated chromaffin granules as a function of 
toxin concentration (panel A), pH (inset, panel A), and 
temperature (panel B); and displacement of 125I-labeled toxin 
by unlabeled toxin or the GDlb ganglioside (panel C). The 
graphs in panels A and C are self-explanatory. In panel B, the 
bars represent 125I-TT binding to untreated (C) and to 
neuraminidase-pretreated (B) granules, while in A the granules 
were treated with neuraminidase after ]25I-binding at the 
indicated temperatures. For experimental details ee text. 
surface specific binding sites for ~25I-tetanus toxin 
(fig.2, panel A), in line with previous findings [23]. 
In contrast, suspensions of chromaffin granules 
showed a capacity for binding the labeled toxin, 
that was saturatable at a concentration of about 
3 × 10 -s M free toxin (fig.2, panel A). Scatchard 
analysis of these data yielded an apparent affinity 
coefficient (Kd) of about 8 x 10-SM and an 
estimated binding capacity of 0.45 nmol/mg 
granule membrane protein (table 1). These values 
are comparable in their low affinity and high 
number of binding sites to the estimates for tetanus 
toxin binding to synaptosomes derived from 
guinea pig and bovine brains, respectively [ 16,17]. 
To localize the TT-binding sites we also 
prepared membranes from intact chromaffin 
granules by osmotic shock and used them either 
fresh or after storage at -70°C.  The isolated 
membranes exhibited binding characteristics for 
the toxin similar to those of intact granules: 
tetanus toxin binding capacity was in the range of 
0.2-0.4 nmol/mg protein concomitant with a 
reduced affinity in the range of 1 × 10-7-5 x 
l0 -7 M. These results might reflect a loss of mem- 
brane proteins and/or their binding properties due 
to the preparation procedure. The similarity in the 
binding properties of TT to intact granules and to 
isolated membranes, before and after rupture by 
osmotic shock or by freezing and thawing suggests, 
that the binding site of TT is located exclusively on 
the cytoplasmic face of the granules. This result is 
unexpected, since TT has been shown to bind to 
complex polysialogangliosides [3] and, hitherto, 
such gangliosides were believed to reside solely on 
the inner face of the granule membranes [24,25]. 
To characterize further the nature of the tetanus 
toxin-binding sites, we pretreated intact chromaf- 
fin granules with purified neuraminidase from 
Table 1 
Binding characteristics of ]251-tetanus toxin to different 
preparations of chromaffin granules 




Isolated intact granules 
Granules + neuramirddase 
Granules + trypsin 
Osmotically shocked fresh granules 
Osmotically shocked frozen granules 
8.0  x 10 -s  0 ,45  
2 .4  × 10 -6 0 ,042  
5 .0  x 10 -7 0 ,011  
1.0 × 10 -7 0 ,40  
5 .0  ),( 10 -7 0 ,20  
Experimental: 125I-tetanus toxin binding to the various granule 
preparation was measured asdetailed in the legend to fig. 1. Kd 
and Bma~ values were obtained from Scatchard plots of the 
binding data, each comprising between 15 and 20 experimental 
points 
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Vibrio cholerae and with trypsin. Removal of the 
sialic acid residues by neuraminidase caused a 
substantial loss (up to 80°70) of the tetanus toxin- 
binding sites at all toxin concentrations (fig.2, 
panel A) and over the entire pH range investigated 
(fig.2, panel A, insert). For example, at pH 6.7, 
neuraminidase treatment reduced tetanus toxin 
binding by 75°7o. Scatchard plot analysis of TT 
binding to neuraminidase-treated granules in- 
dicated a more than 400-fold loss in affinity (Kd = 
2.4 × 10 -4 M). This decrease in TT binding 
paralleled the reduction in total lipid-bound sialic 
acid (data not shown). By contrast, extensive tryp- 
sinization (1 mg/ml for 30 min at 37°C), which 
removes most of the proteins on the granule sur- 
face but leaves the sialoglycolipids intact, reduced 
the affinity for TT binding by a factor of 20 (Kd = 
5 X 10 -7 M). 
The optimum pH for tetanus toxin binding to 
chromaffin granules was found to be around 6.7, 
while at pH 5.5 and at pH > 7.4 binding was 
decreased by more than 50°7o (fig.2, panel A, in- 
set). These results were similar to the bell shaped 
pH dependence observed for tetanus toxin binding 
to neuronal membranes [16,17]. 
Pretreatment of intact chromaffin granules with 
neuraminidase, prior to adding the toxin, caused a
substantial loss of tetanus toxin-binding sites, in- 
dependent of the temperature (4°C or 37°C) at 
which the subsequent experiments were carried out 
(fig.2, panel B). However, the results were more 
difficult o interpret when neuraminidase was add- 
ed after the 125I-TT had bound to the granules at 
different emperatures. When the toxin was first 
allowed to bind to chromaffin granules at 4°C, a 
significant fraction of the bound toxin could be 
removed by neuraminidase (open bars, B). By con- 
trast, the toxin-binding site complex formed at 
37°C was stable and refractive to neuraminidase 
treatment (open bars, A). This finding might 
reflect a process similar to TT sequestration at
37°C that has previously been reported with 
cultures of neuronal cells [19]. 
Displacement of bound TT from chromaffin 
granules (fig.2, panel C) by unlabeled, ganglioside 
affinity purified tetanus toxin or by the ganglioside 
GDlb was observed with ICso values of 1.7 × 10 -v 
and 2.2 × 10 -7 M, respectively. These values are 
about ten times higher than the Kd values for the 
actual binding of the toxin to the granules and are 
consistent with our notion of some irreversible in- 
teraction between the bound toxin and its sites, 
similar to that previously described for toxin se- 
questration i neuronal systems [16,17,19]. 
To provide visual evidence for the specificity 
and the location of tetanus toxin-binding sites, we 
used a biotinylated TT derivative which had been 
purified by chromatofocussing and ganglioside- 
affinity chromatography [20]. After incubation of 
intact chromaffin granules with biotinylated-TT, 
streptavidin-gold (20 nm diameter) was added to 
the preparations. In control experiments, granules 
were pretreated with neuraminidase or incubated 
with streptavidin-gold alone. The preparations 
were then processed for transmission electron 
microscopy. The electron micrographs reveal 
specific tetanus toxin-binding sites on the 
cytoplasmic face of vesicles or vesicular mem- 
branes (fig.3, panels a-d). Although our prepara- 
tions contain a fraction of lysed vesicles with 
partially open membranes, the gold labeling is in- 
variably limited to the outer surface of the 
chromaffin vesicle membranes. In view of the con- 
troversy over the topography of sialic acid residues 
on the chromaffin granule membranes [24,25], 
these electron microscopic images strengthen the 
notion that the sugar-sialic acid conformation 
recognized by the 'Glb'-tetanus toxin is strictly 
localized on the external surface of chromaffin 
granules. When the granules were treated with 
neuraminidase prior to binding of the toxin, prac- 
tically no biotinylated-toxin-streptavidin gold 
complexes were found (fig.3, panel e). In addition, 
the specific binding of the biotinylated toxin to 
chromaffin granules was significantly decreased by 
competition with unlabeled toxin (data not 
shown). The nonspecific binding to the granules of 
the streptavidin-gold probe alone, in the absence 
of the toxin as mediator, was found to be insignifi- 
cant (fig.3, panel f). 
Our tentative identification of tetanus toxin- 
binding sites as polysialoconjugates is upported 
by several lines of evidence: the specific Glb 
ganglioside affinity of the tetanus toxin probe 
[4,11], the high binding capacity of toxin sites and 
their low affinity and, in particular, their sensitivi- 
ty to neuraminidase. In addition, the pH optimum 
for binding, the resistance of the tetanus toxin 
bound at 37°C to neuraminidase tr atment and the 
displacement behavior are entirely consistent with 
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Fig.3. Localization of affinity purified biotinylated tetanus toxin-binding sites, visualized with streptavidin-gold n isolated chromaffin 
granules. (Panels a-d) Untreated chromaffin granules; (panel e) chromaffin granules after neuraminidase treatment; (panel f) the 
biotinylated toxin was omitted to permit evaluation of the nonspecific binding of streptavidin-gold. Bar equals 167 nm in panels 
a,d,e,f, 130 nm in panel b, and 79 nm in panel c. The original magnifications were 60000 x in panels a,d,e,f; 77000 × in panel b; 
and 127000 x in panel c, respectively. 
the binding propert ies of  tetanus toxin to neuronal  
membranes,  where the TT receptors have been 
identi f ied as G lb  type polysialogangl iosides 
[16,17]. 
Chemical  analyses of  ganglioside composi t ion of  
bovine chromaff in  granule membranes have failed 
to detect he presence of  polysialoglycol ipids of  the 
G lb  type [26]. GM3 gangliosides, which are not 
recognized by tetanus toxin [27], were found to ac- 
count for > 95% of  the total  gangl ioside species of  
the chromaff in  granules [24,25]. Therefore,  the 
G lb  structure recognized by tetanus toxin appears 
to be a related glycoconjugate on the cytoplasmic 
face of  chromaff in  granule membranes that 
represents either a very minor  Gd l - l i ke  
poly ia logangl ios ide,  which hitherto has not been 
identif ied [24-26], or a g lycoprotein-proteoglycan 
[28] with a similar sugar-sial ic acid structure. 
F rom our data on tetanus toxin binding to 
granules and toxin inhibit ion of  catecholamine 
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secretion we can also estimate the binding capacity 
o f  permeabilized chromaff in cells. 1 mg of  cellular 
protein corresponds to approx. 3 x 106 chromaff in 
ceils, each containing some 20000 granules [29]. 
Assuming that the granule content of  a chromaff in 
cell represents 15% of  total cellular proteins, then 
1 mg granule protein is equivalent to 4 × 1011 
granules. Estimating an apparent tetanus toxin 
binding capacity of  0.45 nmol /mg granule protein 
(fig.2), then one chromaff in granule binds approx. 
1000 tetanus toxin molecules. Taking into con- 
sideration the known chromaff in cell volume, 
which is 7.5 × 10 -x3 1 [29], and that at maximum 
2 × 107 molecules of  toxin could bind to the 2 × 
104 granules available per chromaff in cell, it is 
estimated that the maximal concentration of  
tetanus toxin required to saturate all the chromaf-  
fin granules in a permeabilized cell would be 4 × 
10 -5 M. This estimation icely coincides with the 
concentration of  tetanus toxin required to inhibit 
catecholamine r lease, experimentally obtained in 
the present study (fig.l). 
Tetanus toxin does not impair catecholamine 
secretion from intact bovine chromaff in cells, 
primari ly because of  the absence of  its putative 
glycolipid receptors on the cell surface [23,30]. 
However,  in neuronal cells which avidly bind this 
toxin, the toxin affects the neurotransmitter 
release following internalization and retrograde 
transport [4,11]. Once the toxin molecules reach 
their site of  action on the granule membranes or, 
alternatively, on the cytoplasmic face of  the 
neuronal cell membrane [19], they might interfere 
directly with the fusion of  the secretory granule 
with the neuronal membrane. While the chemical 
nature of  tetanus toxin-binding sites on chromaf-  
fin granule membranes requires further elucida- 
tion, the present report provides an explanation 
for the inhibitory potency of  tetanus toxin and of 
botul inum D toxin (which recognizes the same type 
of  gangliosides) to block exocytosis [5,7-9]. We 
suggest that the polysialoganglioside(s) or 
glycoprotein(s) on the cytoplasmic face of  the 
chromaff in granule membrane which serve as TT 
receptor are essential for either the docking of  the 
granule membrane to the plasma membrane [31] or 
for the fusion process per se. 
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